Clinical Trial Update: Safety and Feasibility Trial of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia [Phase 2]

View source ↗

Summary

Phase 2 safety and feasibility trial of adipose-derived regenerative cells for chronic myocardial ischemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Ischemia

Drugs mentioned

• Adipose-derived Regenerative Cells (Adipose-derived Regenerative Cells)

Snippet

Sponsor: Cytori Therapeutics | Conditions: Myocardial Ischemia | Phase 2 | Status: COMPLETED